27 July 2020 : Database Analysis
Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
Yanyan Feng1AC, Chunguang Guo2BC, Hesong Wang1B, Lu Zhao1CF, Wei Wang1C, Ting Wang1BC, Yuyin Feng3C, Kai Yuan1BCDF, Guangrui Huang3AEG*DOI: 10.12659/MSM.923531
Med Sci Monit 2020; 26:e923531
Figure 7 GSEA was used to predict the biological functions of FGL2 in breast cancer. (A) Inflammatory response, (B) Interferon-gamma response, (C) Interferon-alpha response, (D) Apoptosis, (E) MYC targets V2, (F) Oxidative phosphorylation (G) DNA repair, (H) Unfolded protein response. (ES – enrichment score; FDR – false discovery rate).